The modeling approaches to investigate dose-response relationships for cancer and noncancer end points, and Other aspects of the protocol and associated documents. The EPA (2019a) document is ...
To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results